Zobrazeno 1 - 10
of 28
pro vyhledávání: '"S. Reiter-Niesert"'
Autor:
W W Bolten, Kommission Pharmakotherapie der DGRh, Klaus Krüger, S Reiter-Niesert, D O Stichtenoth
Publikováno v:
Zeitschrift für Rheumatologie. 75:103-116
NSAR lindern Schmerz und Entzundung durch Hemmung der COX-2 und konsekutive Verminderung der Synthese schmerzvermittelnder Prostaglandine. Unerwunschte Wirkungen limitieren die NSAR-Therapie. Die wichtigsten unerwunschten Wirkungen entstehen gastroin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e00639c79cdc614ad22d3c6dc004087
https://doi.org/10.1007/s00393-015-0018-6
https://doi.org/10.1007/s00393-015-0018-6
Autor:
Andrea Laslop, Eleonora Tajana Messi, Pieter D’Hooghe, René Rizzoli, Olivier Bruyère, S. Reiter-Niesert, Francis Berenbaum, Nigel K Arden, Gabriel Herrero-Beaumont, Jean-Pierre Devogelaer, Cécile Clerc, Johanne Martel-Pelletier, Giuseppe Mautone, Yannis Tsouderos, Jean-Pierre Pelletier, Cyrus Cooper, Lucio C. Rovati, Marc C. Hochberg, Stefania Maggi, Maria Luisa Brandi, Jean-Yves Reginster, F Petit-Dop, Elaine M. Dennison, Véronique Leblanc, Jaime Branco, Eric Abadie, John A. Kanis, Pascal Richette
Publikováno v:
Drugs & Aging
Drugs and Aging
Drugs and Aging, Adis, 2015, 32 (7), pp.525-535. ⟨10.1007/s40266-015-0276-7⟩
Drugs and Aging, 2015, 32 (7), pp.525-535. ⟨10.1007/s40266-015-0276-7⟩
Drugs & Aging, Vol. 32, No 7 (2015) pp. 525-535
Drugs and Aging
Drugs and Aging, Adis, 2015, 32 (7), pp.525-535. ⟨10.1007/s40266-015-0276-7⟩
Drugs and Aging, 2015, 32 (7), pp.525-535. ⟨10.1007/s40266-015-0276-7⟩
Drugs & Aging, Vol. 32, No 7 (2015) pp. 525-535
Funding: This meeting was founded by the European Society for Clinical and Economics Aspect of Osteoporosis and Osteoarthritis, a not for profit organization from Belgium. Osteoarthritis (OA), a disease affecting different patient phenotypes, appears
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1adf705ef2cfa30bf5812abb85f29c2
http://europepmc.org/articles/PMC4516900
http://europepmc.org/articles/PMC4516900
Autor:
Martin Lotz, René Rizzoli, Johanne Martel-Pelletier, Jean-Pierre Pelletier, S. Reiter-Niesert, G. Giacovelli, Olivier Bruyère, Cyrus Cooper, Morten A. Karsdal, Roland Chapurlat, Claus Christiansen, Jean-Yves Reginster, W.E. van Spil, Virginia B. Kraus, Willem F. Lems, Linda J. Sandell, John A. Kanis, Jacques Raynauld, Ingrid Meulenbelt, Julien Collette, Maria Luisa Brandi
Publikováno v:
Lotz, M, Martel-Pelletier, J, Christiansen, C, Brandi, M L, Bruyere, O, Chapurlat, R, Collette, J, Cooper, C, Giacovelli, G, Kanis, J, Karsdal, M, Kraus, V, Lems, W F, Meulenbelt, I, Pelletier, J P, Raynauld, J P, Reiter-Niesert, S, Rizzoli, R, Sandell, L, Van Spil, W & Reginster, J Y 2014, ' Republished: Value of biomarkers in osteoarthritis: current status and perspectives ', Postgraduate Medical Journal, vol. 90, no. 1061, pp. 171-178 . https://doi.org/10.1136/postgradmedj-2013-203726rep
Postgraduate Medical Journal
Postgraduate Medical Journal, 90(1061), 171-178. BMJ Publishing Group
Postgraduate Medical Journal, Vol. 90, No 1061 (2014) pp. 171-178
Postgraduate Medical Journal
Postgraduate Medical Journal, 90(1061), 171-178. BMJ Publishing Group
Postgraduate Medical Journal, Vol. 90, No 1061 (2014) pp. 171-178
Osteoarthritis affects the whole joint structure with progressive changes in cartilage, menisci, ligaments and subchondral bone, and synovial inflammation. Biomarkers are being developed to quantify joint remodelling and disease progression. This art
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e15d5fb8f8e8df70168f302ab9e86b
https://doi.org/10.1136/postgradmedj-2013-203726rep
https://doi.org/10.1136/postgradmedj-2013-203726rep
Autor:
Daniel Pinto, Stuart G. Silverman, Mickaël Hiligsmann, Tore K Kvien, Johan Severens, Jean-Pierre Pelletier, John A. Kanis, Francis Guillemin, Maria Luisa Brandi, Nigel K Arden, David J. Hunter, Lucio C. Rovati, Marc C. Hochberg, Maarten Boers, Andrea Laslop, Olivier Bruyère, Yannis Tsouderos, Jaime Branco, René Rizzoli, S. Reiter-Niesert, Cyrus Cooper, Peter Tugwell, Jean-Yves Reginster
Publikováno v:
Seminars in Arthritis and Rheumatism, 43(3), 303-313. W.B. Saunders
Seminars in Arthritis and Rheumatism, 43(3), 303-313. W.B. Saunders Ltd
Seminars in Arthritis and Rheumatism, 43(3), 303-313. W B Saunders Co-Elsevier Inc
Seminars in Arthritis and Rheumatism, Vol. 43, No 3 (2013) pp. 303-313
Hiligsmann, M, Cooper, C, Arden, N, Boers, M, Branco, J C, Brandi, M L, Bruyere, O, Guillemin, F, Hochberg, M C, Hunter, D J, Kanis, J A, Kvien, T K, Laslop, A, Pelletier, J P, Pinto, D, Reiter-Niesert, S, Rizzoli, R, Rovati, L C, Severens, J L H, Silverman, S, Tsouderos, Y, Tugwell, P & Reginster, J Y 2013, ' Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) ', Seminars in Arthritis and Rheumatism, vol. 43, no. 3, pp. 303-313 . https://doi.org/10.1016/j.semarthrit.2013.07.003
Seminars in Arthritis and Rheumatism, 43(3), 303-313. W.B. Saunders Ltd
Seminars in Arthritis and Rheumatism, 43(3), 303-313. W B Saunders Co-Elsevier Inc
Seminars in Arthritis and Rheumatism, Vol. 43, No 3 (2013) pp. 303-313
Hiligsmann, M, Cooper, C, Arden, N, Boers, M, Branco, J C, Brandi, M L, Bruyere, O, Guillemin, F, Hochberg, M C, Hunter, D J, Kanis, J A, Kvien, T K, Laslop, A, Pelletier, J P, Pinto, D, Reiter-Niesert, S, Rizzoli, R, Rovati, L C, Severens, J L H, Silverman, S, Tsouderos, Y, Tugwell, P & Reginster, J Y 2013, ' Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) ', Seminars in Arthritis and Rheumatism, vol. 43, no. 3, pp. 303-313 . https://doi.org/10.1016/j.semarthrit.2013.07.003
OBJECTIVES: There is an important need to evaluate therapeutic approaches for osteoarthritis (OA) in terms of cost-effectiveness as well as efficacy. METHODS: The ESCEO expert working group met to discuss the epidemiological and economic evidence tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acdfd9eb658affb1f60f72505ea229e4
https://pure.eur.nl/en/publications/a3dfffb8-c4dc-4446-9b36-0d466e6bf9de
https://pure.eur.nl/en/publications/a3dfffb8-c4dc-4446-9b36-0d466e6bf9de
Publikováno v:
Reiter-Niesert, S, Boers, M & Detert, J 2016, ' Short-term placebo response in trials of patients with symptomatic osteoarthritis: differences between hip and knee ', Osteoarthritis and Cartilage, vol. 24, no. 6, pp. 1007-1011 . https://doi.org/10.1016/j.joca.2016.01.002
Osteoarthritis and Cartilage, 24(6), 1007-1011. W.B. Saunders Ltd
Osteoarthritis and Cartilage, 24(6), 1007-1011. W.B. Saunders Ltd
Summary Background In placebo-controlled RCT of symptomatic treatment in osteoarthritis (OA) the extent of pain reduction is heterogeneous, the pooled effect size rather small. Pain reduction is typically higher in knee than in hip trials. The recomm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7342903c8218b60aed59b22bad56658f
https://research.vumc.nl/en/publications/5785f73a-934d-46f9-9038-e9791abb323b
https://research.vumc.nl/en/publications/5785f73a-934d-46f9-9038-e9791abb323b
Publikováno v:
Zeitschrift fur Rheumatologie. 75(1)
NSAIDs exert their anti-inflammatory and analgesic effects by inhibition of COX‑2, a key enzyme for proinflammatory prostanoid synthesis. Therapy with NSAIDs is limited by their typical gastrointestinal, cardiovascular and renal side effects, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60ef79d8f0deab04cf9b9e8252bdfa76
https://pubmed.ncbi.nlm.nih.gov/26768271
https://pubmed.ncbi.nlm.nih.gov/26768271
Autor:
Martin Lotz, Jean-Yves Reginster, Willem F. Lems, Julien Collette, G. Giacovelli, Maria Luisa Brandi, S. Reiter-Niesert, Johanne Martel-Pelletier, Cyrus Cooper, Ingrid Meulenbelt, John A. Kanis, Virginia B. Kraus, J.-P. Raynauld, Roland Chapurlat, Linda J. Sandell, René Rizzoli, Olivier Bruyère, Morten A. Karsdal, Claus Christiansen, W.E. van Spil, Jean-Pierre Pelletier
Publikováno v:
Annals of the Rheumatic Diseases, 72(11), 1756-1763
Lotz, M, Martel-Pelletier, J, Christiansen, C, Brandi, M L, Bruyere, O, Chapurlat, R, Collette, J, Cooper, C, Giacovelli, G, Kanis, J A, Karsdal, M A, Kraus, V, Lems, W F, Meulenbelt, I, Pelletier, J P, Raynauld, J P, Reiter-Niesert, S, Rizzoli, R, Sandell, L J, van Spil, W E & Reginster, J Y 2013, ' Value of biomarkers in osteoarthritis: current status and perspectives ', Annals of the Rheumatic Diseases, vol. 72, no. 11, pp. 1756-1763 . https://doi.org/10.1136/annrheumdis-2013-203726
Annals of the Rheumatic Diseases, Vol. 72, No 11 (2013) pp. 1756-1763
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 72(11), 1756-1763. BMJ Publishing Group
Lotz, M, Martel-Pelletier, J, Christiansen, C, Brandi, M L, Bruyere, O, Chapurlat, R, Collette, J, Cooper, C, Giacovelli, G, Kanis, J A, Karsdal, M A, Kraus, V, Lems, W F, Meulenbelt, I, Pelletier, J P, Raynauld, J P, Reiter-Niesert, S, Rizzoli, R, Sandell, L J, van Spil, W E & Reginster, J Y 2013, ' Value of biomarkers in osteoarthritis: current status and perspectives ', Annals of the Rheumatic Diseases, vol. 72, no. 11, pp. 1756-1763 . https://doi.org/10.1136/annrheumdis-2013-203726
Annals of the Rheumatic Diseases, Vol. 72, No 11 (2013) pp. 1756-1763
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 72(11), 1756-1763. BMJ Publishing Group
Osteoarthritis affects the whole joint structure with progressive changes in cartilage, menisci, ligaments and subchondral bone, and synovial inflammation. Biomarkers are being developed to quantify joint remodelling and disease progression. This art
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a338e073c3464479d3289805fa18ff9
http://hdl.handle.net/1887/100755
http://hdl.handle.net/1887/100755
Autor:
Olivier Bruyère, Jean-Yves Reginster, René Rizzoli, Cyrus Cooper, Maria-Luisa Brandi, S. Reiter-Niesert, Jaime Branco, Stefania Maggi, Gabriel Herrero-Beaumont, Francis Berenbaum, Jean-Pierre Devogelaer, Emmanuel Maheu, John A. Kanis, Pascal Richette
Publikováno v:
Osteoarthritis and Cartilage, Vol. 23, No 12 (2015) pp. 2086-2093
Summary Objective The European Society on Clinical and Economic aspects of Osteoporosis and Osteoarthritis (ESCEO) organised a working group to evaluate the need for updating the current European guideline on clinical investigation of drugs used in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::031cd6d6452dc479dab0ba48a0cab70a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.